COSMOS study results: GUS 100 mg Q8W showed ⬆️ACR20 vs PBO at W24; results of prespecified sensitivity and subgroup analyses were consistent. Safety profile consistent with PsO & biologic-naïve PsA pts. Abstract #OP0230 #EULAR2021 @RheumNow https://t.co/CFN1MHB9yv https://t.co/BOZqyqaHPe